(PharmaNewsWire.Com, March 14, 2019 ) "Global Breast Cancer Diagnosis Market Analysis to 2027" is a specialized and in-depth study of the healthcare IT industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by screening type, technology and geography. The global market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading breast cancer diagnosis market players and offers key trends and opportunities in the market.
We help our clients in making smarter decisions through our custom solutions. We are expert in delivering high quality custom projects in Breast Cancer Diagnostics Industry. The research industry has evolved over a period of time and most of the customers are interested in research as per their requirements.
Increasing prevalence of breast cancer along with advanced technology for its diagnosis is expected to fuel the growth of the breast cancer diagnosis market during the forecast period. Moreover, the introduction of new and better products by manufacturers is anticipated to offer growth opportunities to the companies in the market.
The global breast cancer diagnosis market is segmented on the basis of screening type and technology. Based on screening type, the market is segmented as, laboratory tests, biopsy, imaging, and other screening types. On the basis of technology, the breast cancer diagnosis market is classified as, fluorescent in situ hybridization (FISH), comparative genomic hybridization (CGH), immunohistochemical (IHC), and other technologies.
Breast cancer is the uncontrollable growth of tumour cells in the breasts. Generally, the cancer forms in either the lobules or the ducts of the breast. There are two types of breast cancers, invasive breast cancer and non-invasive breast cancer. During recent years, there has been an increase in the cases of breast cancer in women. Recently, breast cancer is also being detected in men. The American Cancer Society estimated that in 2015, more than 2,000 men would be diagnosed, and more than 400 men would die from the disease.
The List of Companies
1. Abbott 2. F. Hoffmann-La Roche Ltd 3. Fujifilm Holdings Corporation 4. GENERAL ELECTRIC COMPANY 5. Hologic, Inc. 6. Koninklijke Philips N.V. 7. Micrima Limited 8. Provista Diagnostics, Inc. 9. Siemens Healthcare GmbH 10. Thermo Fisher Scientific Inc.
The report analyzes factors affecting breast cancer diagnosis market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the breast cancer diagnosis market in these regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
